An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.

NCT01686633 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1040

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone Furoate/ Vilanterol 200/25 mcg
DRUG: Fluticasone Furoate/ Vilanterol 100/25 mcg
DRUG: Fluticasone Furoate 100 mcg

Sponsor

GlaxoSmithKline